Anticoagulant therapy benign Prostatic Hyperplasia

Cystectomy Humans Male Prostate *Prostatic Hyperplasia/surgery *Transurethral Resection of Prostate Treatment Outcome *Urinary Bladder Neoplasms/surgery Bladder cancer benign prostatic hypertrophy prostate cancer transurethral resection

Mirabegron benign prostatic hyperplasia systematic review meta-analysis

Anticoagulants Humans Male Platelet Aggregation Inhibitors Postoperative Hemorrhage/chemically induced Prostatic Hyperplasia *Transurethral Resection of Prostate

Imidafenacin Overactive Bladder Benign Prostatic Hyperplasia Meta-Analysis

Systematic Review Meta-analysis Holmium Laser Enucleation of Prostate Transurethral Resection of Prostate Benign Prostatic Hyperplasia

膀胱癌 腹腔镜膀胱根治性切除术 机器人辅助膀胱根治性切除术 体腔内尿流改道 体腔外尿流改道 原位新膀胱术

*Cystoscopy Follow-Up Studies Humans Neoplasm Invasiveness Neoplasm Recurrence Local Prospective Studies *Urinary Bladder Neoplasms/diagnosis/therapy Nmibc Non-muscle invasive bladder cancer cystoscopy follow-up

en bloc resection high-risk nonmuscle-invasive bladder cancer reresection systematic review and meta-analysis commercial or financial relationships that could be construed as a potential conflict of interest.

Aged Carcinoma Transitional Cell/*surgery *Cystectomy/methods Female Humans *Lymph Node Excision Male Middle Aged Postoperative Complications Randomized Controlled Trials as Topic Treatment Outcome Urinary Bladder Neoplasms/*surgery

Cystectomy/*methods Humans Length of Stay Postoperative Care/*methods Postoperative Complications/*epidemiology Prospective Studies Recovery of Function Retrospective Studies Standard of Care Urinary Bladder Neoplasms/rehabilitation/*surgery bladder cancer enhanced recovery after surgery meta-analysis postoperative rehabilitation radical cystectomy

Biopsy/methods Carcinoma in Situ/*pathology/*therapy Humans Muscle Smooth Neoplasm Invasiveness Urinary Bladder Neoplasms/*pathology/therapy Biopsias aleatorias de vejiga Carcinoma in situ Non-muscle invasive bladder cancer Random bladder biopsies Tumor vesical no-músculo invasivo

Bladder cancer Pd-1 Pd-l1 atezolizumab avelumab biomarkers durvalumab immunotherapy nivolumab pembrolizumab Urogen licenses/patents: University of Colorado research support: Medivation/Astellas stockholder in: Aurora Oncology PrecisionProfile other: IOS Press (editorial responsibilities compensated).The other authors report no conflicts of interest.

Cisplatin/*therapeutic use Female Humans Male Neoadjuvant Therapy/*methods Urinary Bladder/drug effects/pathology Urinary Bladder Neoplasms/*drug therapy/pathology

Humans Lymph Node Excision Lymph Nodes/*pathology Lymphatic Metastasis/pathology Prognosis Urinary Bladder Neoplasms/diagnosis/*pathology/*therapy

Case-Control Studies Catechol O-Methyltransferase/*genetics Genetic Association Studies Genetic Predisposition to Disease Genotype Humans Kidney Neoplasms/enzymology/*genetics Male Polymorphism Single Nucleotide Prostatic Neoplasms/enzymology/*genetics Risk Factors Urinary Bladder Neoplasms/enzymology/*genetics